Sign up to access historical data
Similar companies
Company | Est. Transaction Value | |
---|---|---|
Gilead SciencesGILD |
-$8,000 | |
AmgenAMGN |
$67,000 | |
Editas MedicineEDIT |
-$8,000 | |
Alnylam PharmaceuticalsALNY |
-$16,000 | |
United TherapeuticsUTHR |
-$210,000 |
Trades by US Politicians
Politician | Filing Date | Type | Size |
---|---|---|---|
Rohit Khanna Democrat | Oct 26, 2023 | Sell | $15K - $50K |
Rohit Khanna Democrat | Oct 2, 2023 | Buy | $1K - $15K |
Lois Frankel Democrat | Sep 8, 2023 | Sell | $1K - $15K |
Lois Frankel Democrat | Jun 29, 2023 | Buy | $1K - $15K |
Rohit Khanna Democrat | Jun 29, 2023 | Sell | $1K - $15K |
Lois Frankel Democrat | Jun 28, 2023 | Buy | $1K - $15K |
Who is the latest politician to buy or sell Bio-Rad shares?
Rohit Khanna sold Bio-Rad shares most recently on October 26, 2023.
Which politician has bought the most BIO stock in the last two years?
Lois Frankel has bought the most BIO stock in the last 2 years, with an estimated value of $16,000.
Which politician has sold the most BIO stock over the last two years?
Rohit Khanna has sold the most BIO stock in the last 2 years, with an estimated value of $41,000.
What is the total value of politicians trading BIO stock in the last 2 years?
The net value of trades by US politicians for Bio-Rad in the last 2 years is negative, amounting to -$25,000. This suggests that US politicians do not believe in the success of the company for various reasons.
How do insider transactions over the last 2 years reflect on Bio-Rad's market confidence?
Over the last 2 years, insider transactions for Bio-Rad have been balanced between buying and selling, showing a neutral stance among insiders towards the company's market performance. This trend of more purchases than sales could be a positive signal to potential investors about the politicians view on the company's future and growth potential.
Why should individual investors pay attention to the stock transactions of US politicians?
Monitoring US politicians' stock trades is valuable because they may have inside information about upcoming policies that could affect stock values, providing investors with valuable clues for making informed decisions.